Study title: A multicenter comparative trial of cefprozil (500 mg QD) versus cefaclor (250 mg TID) in the treatment of tonsillopharyngitis in pediatric patients (final report on study AI414-015).
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Otorhinolaryngologic Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CEFPROZIL | |||||
ATC code: | |||||
Document link: Protocol ai414-015 Cefprozil.pdf | |||||
Document date: 2011-09-21 | |||||
Study number: AI414-015 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |